Final Weeks to Register: 2 Day Pharmaceutical Regulatory Affairs in Asia Training Course - All Important Aspects of Gaining and Maintaining a Successful Marketing Authorisation (June 14-16, 2023) - ResearchAndMarkets.com
10 Apr 2023
Executive Change
DUBLIN--(BUSINESS WIRE)--The "Pharmaceutical Regulatory Affairs in Asia Training Course" conference has been added to ResearchAndMarkets.com's offering.
'Pharmaceutical Regulatory Affairs in Asia Training Course'
This seminar will provide a practical overview of the key areas of pharmaceutical regulatory affairs in Asia, including India, and will cover all important aspects of gaining and maintaining a successful marketing authorisation within the region.
The pharmaceutical market in Asia is growing at a rapid pace and presents both opportunities and challenges to those wishing to work in the region. Rather than a single market, Asia is a collection of different markets, each with their own regulatory processes, although harmonisation exists within the ASEAN countries.
The programme will include:
Discussion of underlying official regulatory sources
An interpretation of practical aspects
An overview of the requirements for local manufacturing
Recent developments
Harmonisation initiatives
An update and wider knowledge of regulatory affairs in Asia
The opportunity to exchange experiences with other delegates
Benefits of attending:
Gain an overview of key Asian markets
Discuss outlines of company and product registration
Understand the application process
Assess the impact of recent regulatory developments in the region
Discuss harmonisation initiatives including ASEAN opportunities
Understand how Japan fits in the Asian regulatory landscape
Discover general, country-specific and regional requirements
Please note that the course will provide an excellent introduction to all the key aspects of regulatory affairs in the Asia region but will not focus specifically or in detail on Chemistry, Manufacture and Control (CMC).
Who Should Attend:
This seminar will be of particular interest to all those who need to learn about successful marketing authorisation applications and in-market regulatory compliance, whether as an introductory or a refresher course.
Previous delegates have included:
Scientists and technical staff in
Regulatory affairs
Registration departments
Medical directors
Key Topics Covered:
Introduction to the Asia Region
Introduction to ASEAN
Philippines
Brunei
PR of China
India
Malaysia
Singapore
Hong Kong
Indonesia
Thailand
Vietnam/Cambodia/Laos
Taiwan
Korea
Outline on Japan
Asean Harmonisation
Speakers:
Monica Dressler-Meyer
DRA Manager
Management Forum
Mónica is DRA Manager based in Switzerland with several years of regulatory experience. She has spent many years in DRA working with different pharmaceutical companies with responsibility for Asia Pacific and lately also for development activities in other regions. Prior to this, she worked at F. Hoffmann-La Roche in Switzerland where she gained several years' experience in industry basics and pre-clinical research. Mónica has a Degree in Chemistry and Biochemistry from Basel University.
Alan Chalmers
Pharmacist
Management Forum
Dr Alan Chalmers is a pharmacist with over 35 industrial experiences mainly in the field of pharmaceutical regulatory affairs. A graduate of Strathclyde University in Glasgow with a B.Sc. in Pharmacy with specialisation in Pharmaceutical Technology, his Ph.D. at Manchester University was in Pharmaceutical Formulation. From 1975-1978 he was Development Officer and Clinical Trials Pharmacist of Allen & Hanburys (part of the then Glaxo group). In 1978 he joined Ciba-Geigy in DRA. Over 20 years were spent with Ciba-Geigy/CIBA/Novartis in all aspects of regulatory affairs including head of a group company DRA in Canada and for many years as Head of Pharma International regulatory affairs.
He has been consultant to the IFPMA, WHO and other international bodies and was Chairman of the Organising Committee of the initial IFPMA Asian Regulatory Conferences in Hong Kong and Singapore and Rapporteur to the more recent conferences in China and Malaysia.
Since 1998 he has been an independent regulatory consultant and is Director of his own consultancy company Pharma International in Switzerland. He has also been director of two UK and Swiss registered pharmaceutical companies with specialised responsibility for international regulatory strategy. More recently as accredited by Swissmedic, Dr. Chalmers is a Qualified Person supporting several Swiss pharmaceutical companies trading internationally with pharmaceuticals and medical devices.
He is published, and his publications include a textbook on International Pharmaceutical Registration, Active Pharmaceutical Ingredients and as Swiss correspondent to the Regulatory Affairs Journals Pharma and Medtech. Since 2012 he has been a member of the Editorial Board, Scrip Regulatory Affairs.
For more information about this conference visit https://www.researchandmarkets.com/r/ylz978
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Indications
-Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.